Boeing Balances MQ-28 Defense Momentum With 777X And Starliner Setbacks
Boeing Company BA | 0.00 |
- Boeing (NYSE:BA) validated the stealth characteristics of its MQ-28 Ghost Bat drone through radar cross section testing.
- The company recently secured large military support and aircraft production contracts, expanding its defense backlog.
- Boeing faces extended certification delays for the 777X program into 2027.
- NASA is conducting a review of Boeing's Starliner operations, adding regulatory focus on its space activities.
Boeing, trading around $217.42, sits at the center of two very different storylines: growing defense activity and extended commercial and space program challenges. The stock is up 4.0% over the past year, while returns over the past 3 and 5 years are roughly flat or down, which keeps attention on how new contracts and program milestones might affect sentiment. For investors following NYSE:BA, these mixed signals across business segments are an important part of the current picture.
The MQ-28 progress and recent contract wins point to a bigger role for defense and autonomous systems within Boeing's overall mix, while delays in the 777X certification timeline and NASA's review of Starliner raise questions about execution risk in other areas. Investors may want to watch how management prioritizes capital and resources across these programs, and how future updates on testing, regulatory reviews, and deliveries shape expectations for the business over the coming years.
Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.
The MQ-28 Ghost Bat stealth validation and fresh multi hundred million dollar military awards underline how important defense is becoming in Boeing’s portfolio, especially as commercial and space programs face execution risk. The Ghost Bat, designed to fly alongside crewed aircraft for surveillance and electronic warfare, positions Boeing directly against defense peers like Lockheed Martin and Northrop Grumman that are also investing in autonomous, low observable systems. At the same time, extended 777X certification into 2027 and NASA’s review of Starliner keep regulatory and timing risk front and center, which can affect how quickly Boeing converts its large backlog into cash.
How This Fits Into The Boeing Narrative
- The MQ-28 progress and recent defense contracts support the narrative’s focus on advanced technology programs and a bigger role for high value government work in offsetting commercial volatility.
- Prolonged 777X and Starliner challenges push against the narrative’s assumption of smoother production ramp ups, as delays can weigh on margins and stretch the recovery timeline for key programs.
- The specific impact of autonomous combat aircraft like Ghost Bat on future mix, profitability, and capital allocation is not fully reflected in the existing storyline, which leans more on commercial aircraft demand and services growth.
Knowing what a company is worth starts with understanding its story. Check out one of the top narratives in the Simply Wall St Community for Boeing to help decide what it's worth to you.
The Risks and Rewards Investors Should Consider
- High debt levels and weaker coverage from operating cash flow reduce financial flexibility if program delays or new issues weigh on cash generation.
- Certification setbacks for the 777X and regulatory scrutiny of Starliner highlight ongoing execution and regulatory risk in complex aerospace programs.
- Trading below some fair value estimates and screening as good value on several checks gives investors a margin of safety if execution improves over time.
- Forecast earnings and revenue growth, alongside strong order and defense backlogs, support the case that Boeing can grow into a healthier earnings profile if key programs stay on track.
What To Watch Going Forward
From here, keep an eye on three things: concrete follow on orders or export deals linked to the MQ-28 program, any further slippage or clarity on 777X and 737 certification milestones, and updates from NASA’s review of Starliner operations. Together, these will help show whether defense growth is starting to offset commercial and space headwinds, and whether management is improving consistency in program execution across the portfolio.
To ensure you're always in the loop on how the latest news impacts the investment narrative for Boeing, head to the community page for Boeing to never miss an update on the top community narratives.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
